BPIT 5-Week Multi-Site Study: Movement Efficiency, Mobility & Neuromuscular Adaptation
NCT ID: NCT07256717
Last Updated: 2025-12-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
369 participants
INTERVENTIONAL
2025-10-10
2026-02-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Ground-Based (Low) Knee-Level (Low-Moderate) Standing (Moderate) Head-Level (Moderate-High) Plyometric (High-Impact)
The study aims to quantify improvements in functional movement efficiency, joint mobility, postural control, strength adaptation, and heart-rate variability while monitoring safety and individual overload indicators.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Change in Functional Movement Screen (FMS) total score from baseline to Week 5 Change in Y-Balance Test reach distance (composite score) Timeframe: Baseline and Week 5
Secondary Outcome Measures
Change in 1-RM or estimated strength (squat, deadlift, overhead press) Change in resting HRV (RMSSD) Change in joint range of motion (goniometry) and postural sway Incidence of training-related discomfort or minor injury Timeframe: Baseline, weekly, and Week 5
Arms/Intervention Experimental: BPIT 5-Line Training Group Intervention: Behavioral: Balanced Progressive Intensity Training (BPIT) 5-Line Method Description: 5-week supervised progressive training using the BPIT 5-Line framework (ground-based → plyometric) Eligibility
Ages Eligible: 18 Years to 65 Years Sexes Eligible: All Accepts Healthy Volunteers: Yes
Inclusion Criteria
Healthy adults with regular exercise history Able to attend 3-5 training sessions/week Signed informed consent
Exclusion Criteria
Recent injury (\<3 months) Known cardiovascular, metabolic, or orthopaedic contraindications Pregnancy
Study Locations 13 Locations in India 2 Locations in USA, (Details of the location is uploaded on mmsxauthority.com webiste)
MMSx Authority , USA, GFFI Fitness Academy, New Delhi BodyGNTX USA BFS/AIHFT-approved facilities
Countries of Recruitment India U.S. FDA-regulated? No / No / No Human Subjects Protection Review Board Status Approved (or Submit for review if not yet) Board Name: Institutional Ethics Committee - MMSx Authority / GFFI Approval Number: BPIT-MULTI-2025-001 (or pending) Data Monitoring Committee No
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BPIT 5-Line Training Group
All participants receive the 5-week Balanced Progressive Intensity Training (BPIT) program using the 5-Line Principle (ground-based → knee-level → standing → head-level → plyometric) under supervised sessions 3-5 times per week.
Balanced Progressive Intensity Training (BPIT) 5-Line Method
5-week supervised progressive training using the BPIT 5-Line framework developed by Dr. Neeraj Mehta.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Balanced Progressive Intensity Training (BPIT) 5-Line Method
5-week supervised progressive training using the BPIT 5-Line framework developed by Dr. Neeraj Mehta.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BodyGNTX Fitness Institute
UNKNOWN
GFFI Fitness Academy
UNKNOWN
Indian Institute of Kinesiology and Biomechanics Science (IIKBS)
UNKNOWN
Bureau of Fitness Standards (BFS)
UNKNOWN
Active India Health & Fitness Trust (AIHFT)
UNKNOWN
Body Mechanic Chain of Gyms
UNKNOWN
Shri Mahaveer Ortho Clinic
UNKNOWN
Regain Fitness Zone
UNKNOWN
MMSx Authority Biomechanics Department
UNKNOWN
MMSx Authority Institute for Movement Mechanics & Biomechanics Research Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BodyGNTX Fitness Institute
Columbus, Ohio, United States
MMSx Authority Biomechanics Department
Powell, Ohio, United States
MMSx AUTHORITY INSTITUTE FOR MOVEMENT MECHANICS & BIOMECHANICS RESEARCH (COORDINATING CENTER)
Powell, Ohio, United States
Indian Institute of Kinesiology & Biomechanics Science (IIKBS)
Burhānpur, Madhya Pradesh, India
Shri Mahaveer Ortho Clinic
Delhi, National Capital Territory of Delhi, India
GFFI Fitness Academy
New Delhi, National Capital Territory of Delhi, India
Active India Health & Fitness Trust (AIHFT)
New Delhi, National Capital Territory of Delhi, India
Body Mechanics Gym P Ltd
New Delhi, National Capital Territory of Delhi, India
Regain Fitness Zone
Greater Noida, Uttar Pardesh, India
GFFI Fitness Academy
Agra, Uttar Pradesh, India
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Sunita Malhotra, GCP
Role: backup
Karun Jain, MBBS
Role: backup
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MACREB-BPIT-2025-014
Identifier Type: OTHER
Identifier Source: secondary_id
BPIT-MULTI-2025-001
Identifier Type: -
Identifier Source: org_study_id